Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) refers to chronic inflammatory conditions of the intestines, including Crohn's disease and ulcerative colitis. The gastroenterology and gastrointestinal (GI) surgery program at Cedars-Sinai is ranked as the No. 1 program in California, and the No. 3 program nationwide. The internationally recognized IBD specialists at Cedars-Sinai are dedicated to providing outstanding, patient-centered care for the management of IBD, and are engaged in groundbreaking research to help cure these diseases.
This unique program provides dietary and alternative strategies for the treatment of IBD to help optimize quality of life and potentially minimize symptoms and disease activity.
The Inflammatory Bowel and Immunobiology Research Institute provides patients with access to the latest clinical trials and research into new therapies, and is home to the largest IBD research registry in the world.
Learn about the latest clinical trials being conducted at the Cedars-Sinai Inflammatory Bowel Disease Center to find new treatments for Crohn's disease, ulcerative colitis and other inflammatory bowel diseases.
The Inflammatory Bowel Disease Center offers graduate and continuing medical education, advanced fellowship programs, physician-to-physician consultations and referrals.